SHERRI KEGERREIS: Open Payments
NPI 1285891143 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 17 payments from 14 companies in 2025. Trend: 2023 $15 · 2024 $84 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $44 |
| Janssen Biotech, Inc. | 2 | $32 |
| BeOne Medicines USA, Inc. | 2 | $31 |
| Aveo Pharmaceuticals, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| SpringWorks Therapeutics, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| TAIHO ONCOLOGY, INC. | 1 | $16 |
Products named: BRUKINSA, REBLOZYL, FOTIVDA, KEYTRUDA, LIBTAYO, OGSIVEO, Nubeqa, Lenvima.
Industry payments across FL — which companies pay providers there.
